Analysis of the integration of human papillomaviruses in head and neck tumours in relation to patients' prognosis

International Journal of Cancer

Volumn 138, Issue 2, 2016, Pages 386-395

  Vojtechova, Zuzana ^a   Sabol, Ivan ^a   Salakova, Martina ^a   Turek, Lubomir ^c   Grega, Marek ^b   Smahelova, Jana ^a   Vencalek, Ondrej ^d   Lukesova, Eva ^a,e   Klozar, Jan ^e   Tachezy, Ruth ^a,b  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c UNIVERSITY OF IOWA   (United States)

^d PALACKÝ UNIVERSITY   (Czech Republic)

^e UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

head and neck tumours; HPV; integration; prognosis; survival

Indexed keywords

COMPLICATION; FEMALE; GENETICS; HEAD AND NECK TUMOR; HUMAN; MALE; MORTALITY; PAPILLOMAVIRUS INFECTION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SOUTHERN BLOTTING; SQUAMOUS CELL CARCINOMA; TONSIL TUMOR; VIROLOGY; VIRUS DNA CELL DNA INTERACTION;

BLOTTING, SOUTHERN; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TONSILLAR NEOPLASMS; VIRUS INTEGRATION;

EID: 84955748803     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29712     Document Type: Article

References (47)

1. Simard EP, Torre LA, Jemal A., International trends in head and neck cancer incidence rates: differences by country, sex and anatomic site. Oral Oncol 2014; 50: 387-403.
2. Gaykalova DA, Mambo E, Choudhary A, et al,. Novel insight into mutational landscape of head and neck squamous cell carcinoma. PLoS One 2014; 9: e93102.
3. Zygogianni AG, Kyrgias G, Karakitsos P, et al,. Oral squamous cell cancer: early detection and the role of alcohol and smoking. Head Neck Oncol 2011; 3: 2.
4. Dayyani F, Etzel CJ, Liu M, et al,. Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol 2010; 2: 15.
5. D'Souza G, Kreimer AR, Viscidi R, et al,. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007; 356: 1944-56.
6. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 2007; 90: 1-636.
7. St Guily JL, Jacquard AC, Pretet JL, et al,. Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in france-the EDiTH VI study. J Clin Virol 2011; 51: 100-104.
8. Mighty KK, Laimins LA., The role of human papillomaviruses in oncogenesis. Recent Results Cancer Res 2014; 193: 135-148.
9. Kalantari M, Karlsen F, Kristensen G, et al,. Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis. Int J Gynecol Pathol 1998; 17: 146-153.
10. Jeon S, Lambert PF., Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: Implications for cervical carcinogenesis. Proc Natl Acad Sci U S A 1995; 92: 1654-58.
11. Klaes R, Woerner SM, Ridder R, et al,. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 1999; 59: 6132-36.
12. Munger K, Baldwin A, Edwards KM, et al,. Mechanisms of human papillomavirus-induced oncogenesis. J Virol 2004; 78: 11451-60.
13. Hopman AH, Smedts F, Dignef W, et al,. Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities. J Pathol 2004; 202: 23-33.
14. Pett M, Coleman N., Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis? J Pathol 2007; 212: 356-67.
15. Lace MJ, Isacson C, Anson JR, et al,. Upstream regulatory region alterations found in human papillomavirus type 16 (HPV-16) isolates from cervical carcinomas increase transcription, ori function, and HPV immortalization capacity in culture. J Virol 2009; 83: 7457-66.
16. Hafner N, Driesch C, Gajda M, et al,. Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts. Oncogene 2008; 27: 1610-1617.
17. Olthof NC, Speel EJ, Kolligs J, et al,. Comprehensive analysis of HPV16 integration in OSCC reveals no significant impact of physical status on viral oncogene and virally disrupted human gene expression. PLoS One 2014; 9: e88718.
18. Wentzensen N, Vinokurova S, von Knebel Doeberitz M., Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res 2004; 64: 3878-84.
19. Thorland EC, Myers SL, Gostout BS, et al,. Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene 2003; 22: 1225-37.
20. Kraus I, Driesch C, Vinokurova S, et al,. The majority of viral-cellular fusion transcripts in cervical carcinomas cotranscribe cellular sequences of known or predicted genes. Cancer Res 2008; 68: 2514-22.
21. Lace MJ, Anson JR, Klussmann JP, et al,. Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancers. J Virol 2011; 85: 1645-54.
22. Schmitz M, Driesch C, Jansen L, et al,. Non-random integration of the HPV genome in cervical cancer. PLoS One 2012; 7: e39632.
23. Khoury JD, Tannir NM, Williams MD, et al,. Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-seq. J Virol 2013; 87: 8916-26.
24. Luft F, Klaes R, Nees M, et al,. Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells. Int J Cancer 2001; 92: 9-17.
25. Cricca M, Morselli-Labate AM, Venturoli S, et al,. Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions. Gynecol Oncol 2007; 106: 549-57.
26. Xu B, Chotewutmontri S, Wolf S, et al,. Multiplex identification of human papillomavirus 16 DNA integration sites in cervical carcinomas. PLoS One 2013; 8: e66693.
27. Gao G, Johnson SH, Kasperbauer JL, et al,. Mate pair sequencing of oropharyngeal squamous cell carcinomas reveals that HPV integration occurs much less frequently than in cervical cancer. J Clin Virol 2014; 59: 195-200.
28. Vinokurova S, Wentzensen N, Kraus I, et al,. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res 2008; 68: 307-13.
29. Koskinen WJ, Chen RW, Leivo I, et al,. Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck. Int J Cancer 2003; 107: 401-406.
30. Smeets SJ, Braakhuis BJM, Abbas S, et al,. Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus. Oncogene 2006; 25: 2558-64.
31. Deng Z, Hasegawa M, Kiyuna A, et al,. Viral load, physical status, and E6/E7 mRNA expression of human papillomavirus in head and neck squamous cell carcinoma. Head Neck 2013; 35: 800-808.
32. Tachezy R, Smahelova J, Kaspirkova J, et al,. Human papillomavirus type-specific prevalence in the cervical cancer screening population of Czech women. PLoS One 2013; 8: e79156.
33. Tachezy R, Klozar J, Salakova M, et al,. HPV and other risk factors of oral cavity/oropharyngeal cancer in the Czech republic. Oral Dis 2005; 11: 181-85.
34. Smeets SJ, Hesselink AT, Speel EJ, et al,. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007; 121: 2465-72.
35. De Marco L, Gillio-Tos A, Bonello L, et al,. Detection of human papillomavirus type 16 integration in pre-neoplastic cervical lesions and confirmation by DIPS-PCR and sequencing. J Clin Virol 2007; 38: 7-13.
36. Rotnaglova E, Tachezy R, Salakova M, et al,. HPV involvement in tonsillar cancer: prognostic significance and clinically relevant markers. Int J Cancer 2011; 129: 101-10.
37. Hafkamp HC, Manni JJ, Haesevoets A, et al,. Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer 2008; 122: 2656-64.
38. Mooren JJ, Kremer B, Claessen SM, et al,. Chromosome stability in tonsillar squamous cell carcinoma is associated with HPV16 integration and indicates a favorable prognosis. Int J Cancer 2013; 132: 1781-89.
39. Wieser R., The oncogene and developmental regulator EVI1: EXPRESSION, biochemical properties, and biological functions. Gene 2007; 396: 346-57.
40. Metais JY, Dunbar CE., The MDS1-EVI1 gene complex as a retrovirus integration site: impact on behavior of hematopoietic cells and implications for gene therapy. Mol Ther 2008; 16: 439-49.
41. Chen D, Vollmar M, Rossi MN, et al,. Identification of macrodomain proteins as novel O-acetyl-ADP-ribose deacetylases. J Biol Chem 2011; 286: 13261-271.
42. Ragin CC, Reshmi SC, Gollin SM., Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line. Int J Cancer 2004; 110: 701-709.
43. Moriarty HT, Webster LR., Fragile sites and bladder cancer. Cancer Genet Cytogenet 2003; 140: 89-98.
44. Lagana A, Russo F, Sismeiro C, et al,. Variability in the incidence of miRNAs and genes in fragile sites and the role of repeats and CpG islands in the distribution of genetic material. PLoS One 2010; 5: e11166.
45. Dahlstrand H, Nasman A, Romanitan M, et al,. Human papillomavirus accounts both for increased incidence and better prognosis in tonsillar cancer. Anticancer Res 2008; 28: 1133-38.
46. Nambaru L, Meenakumari B, Swaminathan R, et al,. Prognostic significance of HPV physical status and integration sites in cervical cancer. Asian Pac J Cancer Prev 2009; 10: 355-60.
47. Shin HJ, Joo J, Yoon JH, et al,. Physical status of human papillomavirus integration in cervical cancer is associated with treatment outcome of the patients treated with radiotherapy. PLoS One 2014; 9: e78995.